Aktie A2QPPY IRIS ACQUISITION CORP
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Iris Acquisition Corp

Aktien

A2QPPY

US89601Y1010

IRAA

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:01 25.04.2024 		% 5 Tage % 1. Jan.
10.38 USD -2.35% Intraday Chart für Iris Acquisition Corp -2.26% +0.48%
17.04. Iris Acquisition Corp meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
12.01. Iris Acquisition Corp meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023
Iris Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Iris Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K
Iris Acquisition Corp announced that it has received $1.5 million in funding
Iris Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Iris Acquisition Corp Appoints Nicholas Fernandez as Director
Iris Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2023
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)
Iris Acquisition Corp Announces Resignation of Borade as A Member of the Board
IRIS ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Iris Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022
FTX revival effort draws possible bid from VC firm Tribe Capital - Bloomberg News
Iris Acquisition Corp Auditor Raises 'Going Concern' Doubt
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
IRIS ACQUISITION CORP : Change in Directors or Principal Officers (form 8-K)
Iris Acquisition Corp Appoints Borade Shashibhushan to Serve as A Director
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
IRIS ACQUISITION CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
IRIS ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QPPY Aktie
  4. Nachrichten Iris Acquisition Corp
  5. Andere Sprachen